Drawing for GENET GENE THERAPY CENTER OF EXCELLENCE PORTUGAL

USPTO serial 79410458

GENET GENE THERAPY CENTER OF EXCELLENCE PORTUGAL

Reviewed by CopyMark Law Group

Reg. 7989050Status 700Registered
Filing date
Status date
Registration date
Oct 21, 2025
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENET GENE THERAPY CENTER OF EXCELLENCE PORTUGAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Lee D'Amore

Elizabeth Lee D'Amore Lucas & Mercanti, LLP100 S. Jefferson Road, Suite 202Whippany, NJ 07981United States

Goods and services

ClassDescriptionStatusFirst use
042Computer aided scientific analysis services; laboratory analysis in the field of cosmetics; laboratory analysis in the field of bacteriology; laboratory analysis in the field of chemistry; design and development of medical technology; scientific and technological services, namely, research and design in the field of gene therapy; advisory services relating to gene therapy; technological consultancy services in the field of gene therapy research and development; product design and development in the field of gene therapy; consultancy in the field of industrial research; consultancy in the field of scientific research; technical consultancy relating to product development; development of testing methods; development of new technology for others; development of new products; development of industrial processes; development of consumer products; development of industrial products; development of measuring probes for biotechnological applications; provision of scientific information; preparation of scientific reports; preparation of reports relating to scientific research; chemical engineering; expert opinion relating to technology; technical writing; conducting technical project studies; conducting technical project studies; conducting technical project studies; conducting technical project studies; technological research; providing scientific research information and results from an online searchable database in the field of gene therapy; provision of information relating to technological research in the field of gene therapy; provision of research services in the field of gene therapy scientific research relating to hair care preparations; scientific research relating to cosmetics; genetic testing for scientific research purposes; cosmetics research for others; research of new products for others; product research; research in the field of dna chip technology; research in the field of dna repair technology; research and development of new products; research and development of new products for third parties in the field of plastic materials; cosmetic research; industrial process research; genetic research; industrial research; research laboratories; laboratory research in the field of cosmetics research in the field of bioengineering; research in the field of synthetic biology; bioinorganic chemistry research; research of induced pluripotent stem cells; research in the field of hair care; research in the field of gene editing technology; RNA interference technology research; technological research in the field of data mining; chemical technological research; technological research relating to iris recognition; technical research in the field of 3d optical measurement; technical research in the field of computer vision; laboratory research in the field of gene therapy; genetic mapping for scientific purposes; scientific research in the field of gene therapy; computer aided scientific research services; scientific research conducted using databases; laboratory research in the field of gene expression; research and development of new products for others; research and development of new products for others; research in the field of materials science; scientific research for medical purposes; technical research in the field of gene therapy; technical project planning; preparation of project analysis studies; preparation of technical studies; preparation of technical manuals; preparation of reports relating to technical research; preparation of technological research reports; preparation of technological reports; providing on-line information in the field of technological research from a computer database or the internet; provision of information relating to scientific research; technical research projects and studies; conducting technical project studies; conducting industrial experiments; conducting industrial tests; technical writing; technical writing for others; scientific services; scientific laboratory services; scientific and technological services; contract research services relating to molecular sciences; dna analysis services for scientific research purposes; technical data analysis services; blood analysis services for scientific research purposes; analysis of industrial fluids; blood analysis services for scientific research purposes; industrial analysis and research services in the field of chemistry; advisory services relating to scientific instruments; advisory services relating to scientific research; natural science services, namely biology and chemistry services such as development and production of drug delivery strategies, toxicity studies, cloning services, vector engineering, genome engineering, genome editing, biomarkers development, protein engineering, optimization of drugs; technological design services; consultancy services in the field of technological development; technical consultancy services relating to electrocardiograms; technical consultancy services relating to computer programming; research services; drug discovery services; scientific research and development; research and development in the field of biotechnology; industrial research; mathematical research services; cell separation research services; research to develop new products; analytical laboratory services; medical and pharmacological research services; scientific laboratory services; optical research laboratory services; spectral analysis measurement services; research and development services in the field of engineering; research and development services in the field of antibodies; technological planning services; expert reporting services relating to technology; cell separation technology services; scientific testing services; dna testing services to determine paternity (laboratory services); computer aided diagnostic testing services; laboratory testing of materials; laboratory services in the field of gene therapy; laboratory services for analytical testing; non-medical, ultrasound imaging services; services for the development of methods of testing; services for the provision of technological information; scientific and technological services, namely, scientific research, analysis and testing in the field of gene therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 7, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 30, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 30, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 20, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 21, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 27, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 1, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 1, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 30, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 2024DOCKASSIGNED TO EXAMINER—
Nov 25, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance